Skip to Main Content

As the race to develop a Covid-19 vaccine accelerates, Inovio Pharmaceuticals (INO) filed a lawsuit claiming it is being held “hostage” by its long-standing contract manufacturer, which is refusing to provide crucial data needed to scale up vaccine production.

In arguing its case, Inovio maintained that a supply agreement requires VGXI to transfer technology know-how to other contract manufacturers if it declines to make a vaccine for Inovio. And recently, VGXI told Inovio that it cannot manufacture further batches of its experimental Covid-19 vaccine this year because it lacks manufacturing capacity, according to the lawsuit filed in a Pennsylvania state court.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • During a pandemic and with co-operation among many biotechs it is immoral to withhold manufacturing information. Whether they have a breakthrough vaccine or not, please let me know how you would suggest we might put pressure on VGXI for this deplorable action? Thanks

Comments are closed.